Outlook Therapeutics Inc
F:41O
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Outlook Therapeutics Inc
F:41O
|
US |
|
Everbright Securities Co Ltd
F:0EC
|
CN |
|
What's Cooking Group NV
F:BD0
|
BE |
|
J
|
JAFCO Group Co Ltd
XMUN:JAF
|
JP |
|
P
|
Pinnacle West Capital Corp
LSE:0KIT
|
US |
|
Barrick Gold Corp
TSX:ABX
|
CA |
|
U
|
UOB-Kay Hian Holdings Ltd
F:4LJ
|
SG |
|
UOB-Kay Hian Holdings Ltd
SGX:U10
|
SG |
|
C
|
CH Robinson Worldwide Inc
SWB:CH1A
|
US |
|
Zhejiang CFMoto Power Co Ltd
SSE:603129
|
CN |
|
H
|
Haier Smart Home Co Ltd
SWB:690D
|
CN |
Wall St Price Targets
41O Price Targets Summary
Outlook Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for 41O is 3.72 EUR with a low forecast of 0.33 EUR and a high forecast of 6.96 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 41O's stock price target?
Price Target
3.72
EUR
According to Wall Street analysts, the average 1-year price target for 41O is 3.72 EUR with a low forecast of 0.33 EUR and a high forecast of 6.96 EUR.
What is the Revenue forecast for Outlook Therapeutics Inc?
Projected CAGR
55%
Over the last 10 years, the compound annual growth rate for Revenue has been -12%. The projected CAGR for the next 8 years is 55%.
What is the Gross Profit forecast for Outlook Therapeutics Inc?
Projected CAGR
558%
The compound annual growth rate for Gross Profit over the next 3 years is 558%.
